Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Citi
Johnson and Johnson
Baxter
Cantor Fitzgerald
Cipla
Teva
Colorcon
Novartis
US Department of Justice

Generated: February 21, 2018

DrugPatentWatch Database Preview

Isradipine - Generic Drug Details

« Back to Dashboard

Pharmacology for isradipine
Medical Subject Heading (MeSH) Categories for isradipine

US Patents and Regulatory Information for isradipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Elite Labs Inc ISRADIPINE isradipine CAPSULE;ORAL 077169-002 Apr 24, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Elite Labs Inc ISRADIPINE isradipine CAPSULE;ORAL 077169-001 Apr 24, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Teva ISRADIPINE isradipine CAPSULE;ORAL 077317-002 Jan 5, 2006 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-001 Jun 1, 1994 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Smithkline Beecham DYNACIRC isradipine CAPSULE;ORAL 019546-002 Dec 20, 1990 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Teva ISRADIPINE isradipine CAPSULE;ORAL 077317-001 Jan 5, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc ISRADIPINE isradipine TABLET, EXTENDED RELEASE;ORAL 201067-002 Nov 27, 2015 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc ISRADIPINE isradipine TABLET, EXTENDED RELEASE;ORAL 201067-001 Nov 27, 2015 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-002 Jun 1, 1994 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Smithkline Beecham DYNACIRC isradipine CAPSULE;ORAL 019546-001 Dec 20, 1990 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for isradipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-002 Jun 1, 1994 ➤ Sign Up ➤ Sign Up
Smithkline Beecham DYNACIRC isradipine CAPSULE;ORAL 019546-001 Dec 20, 1990 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-001 Jun 1, 1994 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-002 Jun 1, 1994 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-002 Jun 1, 1994 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-001 Jun 1, 1994 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-001 Jun 1, 1994 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-002 Jun 1, 1994 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-001 Jun 1, 1994 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-001 Jun 1, 1994 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
AstraZeneca
McKesson
Chubb
Daiichi Sankyo
Medtronic
Harvard Business School
Fish and Richardson
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot